Mycobacterium abscessus is an opportunistic pathogen that mainly colonizes and infects
cystic fibrosis patients' lungs. M. abscessus is naturally resistant to many antibiotics such as …

In recent years, Mycobacterium abscessus has appeared as an emerging pathogen, with an
increasing number of disease cases reported worldwide that mainly occur among patients …

Welcome to the 29th edition of Nelson's Pediatric Antimicrobial Therapy, the third edition
written during the COVID-19 pandemic, which continues to significantly affect our lives and …

The Mycobacterium abscessus complex is a group of emerging pathogens that are difficult
to treat. There are no effective drugs for successful M. abscessus pulmonary infection …

Biofilm formation by Mycobacterium fortuitum causes serious threats to human health due to
its increased contribution to nosocomial infections. In this study, the first comprehensive …

Nontuberculous mycobacteria can cause minimally symptomatic self-limiting infections to
progressive and life-threatening disease of multiple organs. Several factors such as …

There is a global increasing number of Mycobacterium abscessus infections, especially
pulmonary infections. Reduced therapeutic options exist against this opportunistic pathogen …

Infections caused by nontuberculous mycobacteria (NTM) are increasing worldwide,
resulting in a new global health concern. NTM treatment is complex and requires …

Nontuberculous mycobacteria (NTM) can cause severe pulmonary disease in people with
cystic fibrosis (pwCF). These infections present unique challenges for diagnosis and …

Background Mycobacterium houstonense is a rapidly growing mycobacterium (RGM) that
belongs to the unnamed third biovariant complex of the Mycobacterium fortuitum group …